Прати
Alan Dal Pra
Alan Dal Pra
University of Miami Miller School of Medicine
Верификована је имејл адреса на med.miami.edu
Наслов
Навело
Навело
Година
Genomic hallmarks of localized, non-indolent prostate cancer
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359-364, 2017
6532017
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736-745, 2015
5602015
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
4072014
Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response
VE Zannella, A Dal Pra, H Muaddi, TD McKee, S Stapleton, J Sykes, ...
Clinical cancer research 19 (24), 6741-6750, 2013
3372013
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies
MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ...
European urology 72 (5), 665-674, 2017
1902017
A systematic review of the evidence for the decipher genomic classifier in prostate cancer
NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ...
European urology 79 (3), 374-383, 2021
1612021
IDH mutation status in prostate cancer
AF Ghiam, RA Cairns, J Thoms, A Dal Pra, O Ahmed, A Meng, TW Mak, ...
Oncogene 31 (33), 3826-3826, 2012
952012
Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy
B Malla, DM Aebersold, A Dal Pra
Journal of translational medicine 16, 1-13, 2018
802018
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response
JW Thoms, A Dal Pra, PH Anborgh, E Christensen, N Fleshner, C Menard, ...
British journal of cancer 107 (5), 840-846, 2012
752012
Exosomes and exosomal microRNAs in prostate cancer radiation therapy
B Malla, K Zaugg, E Vassella, DM Aebersold, A Dal Pra
International Journal of Radiation Oncology* Biology* Physics 98 (5), 982-995, 2017
732017
Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
B Bojaxhiu, AJ Templeton, O Elicin, M Shelan, K Zaugg, M Walser, ...
Radiation oncology 13, 1-9, 2018
662018
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
T Zilli, V Achard, A Dal Pra, N Schmidt-Hegemann, BA Jereczek-Fossa, ...
Radiotherapy and Oncology 176, 199-207, 2022
602022
An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy
RG Bristow, A Berlin, A Dal Pra
The British journal of radiology 87 (1035), 20130753, 2014
572014
Segmentation of prostate and prostate zones using deep learning: A multi-MRI vendor analysis
O Zavala-Romero, AL Breto, IR Xu, YCC Chang, N Gautney, A Dal Pra, ...
Strahlentherapie und Onkologie 196, 932-942, 2020
562020
Objective consensus from decision trees
PM Putora, CM Panje, A Papachristofilou, AD Pra, T Hundsberger, ...
Radiation oncology 9, 1-8, 2014
562014
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist
J Cacicedo, A Navarro, O Del Hoyo, A Gomez-Iturriaga, F Alongi, ...
The British journal of radiology 89 (1067), 20160217, 2016
552016
Synergistic action of image-guided radiotherapy and androgen deprivation therapy
JA Locke, AD Pra, S Supiot, P Warde, RG Bristow
Nature Reviews Urology 12 (4), 193-204, 2015
552015
TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair
A Dal Pra, E Lalonde, J Sykes, F Warde, A Ishkanian, A Meng, C Maloff, ...
Clinical cancer research 19 (18), 5202-5209, 2013
522013
Combining radiation therapy and androgen deprivation for localized prostate cancer—a critical review
A Dal Pra, FL Cury, L Souhami
Current Oncology 17 (5), 28, 2010
522010
The role of radiomics in prostate cancer radiotherapy
R Delgadillo, JC Ford, MC Abramowitz, A Dal Pra, A Pollack, R Stoyanova
Strahlentherapie und Onkologie 196, 900-912, 2020
422020
Систем тренутно не може да изврши ову радњу. Пробајте поново касније.
Чланци 1–20